FountainRx does not publish hormone or testosterone replacement price lists on fountainrx.com. Recurring hormone and TRT prescriptions for referred patients follow its insurance-driven model: coverage review, prior authorization when plans require it, financial assistance when available, and out-of-pocket communicated to the patient after coordination. Rate stability across monthly refills depends on plan design and assistance limits — not a clinic-negotiated per-vial contract.
This page covers recurring cost in FountainRx's specialty model and how cash-pay hormone clinics use visible per-vial COGS for margin planning.
Proudly Partnered With
Hormone and TRT economics are recurring: cypionate, creams, troches, and adjunct therapies refill monthly or on multi-week cadences. FountainRx supports patients with refill reminders, education, and coordination with physicians and insurers per its FAQ. Patient out-of-pocket can shift when deductibles reset, formulary tiers change, or assistance caps — FountainRx does not offer clinics a fixed per-vial TRT rate sheet to model twelve months of COGS upfront. Cash-pay hormone clinics need that stability from visible 503A landed cost instead.
Coverage continuity: does the patient's plan cover the prescribed hormone formulation and route across refills? PA renewal: do prior authorizations expire mid-year? Assistance durability: if copay cards apply, do they cover the full refill cadence or exhaust mid-program?
Set patient expectations that specialty hormone cost is not one fixed monthly number until coordination completes.
Cash-pay hormone clinics sell monthly or quarterly programs priced on landed medication cost times expected refills. Fizy Health shows resolved per-vial 503A cost on each hormone line before checkout, with a disclosed facilitation fee at payment.
Rate stability matters: compare per-vial cost on the formulations you standardize across partners before you lock patient pricing.
Referred patients need recurring specialty coordination.
Cash-pay TRT programs with stable visible per-vial COGS.
FountainRx pricing is patient-specific after insurance review. These outcomes apply when per-vial 503A cost is on the screen before you order for cash-pay protocols.
See resolved 503A landed cost on each catalog and cart line before checkout, with a disclosed facilitation fee at payment.
Build every patient's order in one clinic cart and see each line's cost before you submit a single payment.
Browse GLP-1s, hormones, and peptides from all assigned compounders in one catalog with pricing on each line.
No. FountainRx does not publish hormone or TRT price lists. Patient out-of-pocket depends on insurance, prior authorization, and assistance programs, communicated after coordination per its FAQ.
Not necessarily. Deductible resets, formulary changes, and assistance limits can shift out-of-pocket from fill to fill. Confirm recurring cost expectations with coordinators.
FountainRx serves referred patients with insurance coordination, not clinic wholesale hormone ordering. Cash-pay TRT clinics typically need pass-through per-vial cost visible before checkout.
Fizy Health shows resolved per-vial 503A cost on each hormone line before checkout for cash-pay clinic protocols, with a disclosed facilitation fee at payment.
Build program pricing from landed per-vial cost on the formulations you standardize, multiplied by expected refills. Visible catalog COGS beats guessing patient-specific insurance outcomes for cash-pay models.
Depends on the plan and medication. FountainRx coordinators submit and track prior authorization when insurers require it, per its referral process materials.
Sources reviewed June 2026
Compare landed cost on your standard hormone SKUs, batch refill day in one cart, and quote programs on real numbers. Free to start.